Canyam
AI summaries for academic research
Home
Preprint
Subscribe
Favorites
Tools
Analysis
Summary
Not logged in
Back
Journal Details
D
Diabetes and Metabolism
IF
4.7
Papers
113
Citations
4283
Related Insights
0
subscribe
Journal Papers
98
Related Insights
0
Journal Papers
98
Publication Date
Publication Date
IF
Citations
Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?
Diabetes & Metabolism
IF
4.7
2025-12-16
0
PRE
AI
Jean-Pierre Riveline; Colin Hopley; Anamaria-Vera Olivieri; Gabriel Guigand; Melanie Littlewood; Alfred Penfornis
Share
Save
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis
Diabetes & Metabolism
IF
4.7
2025-12-04
0
PRE
AI
Elise Berchoux; Ilan Szwarc; Jean-Baptiste Bonnet; Joanna Pissarra; Antoine Avignon; Sébastien Jugant; Moglie Lequintrec; Ariane Sultan
Share
Save
Epicardial adipose tissue measurement is an interesting biomarker for cardiovascular health in a case control study of patients with familial partial type 2 lipodystrophy
Diabetes & Metabolism
IF
4.7
2025-12-03
0
PRE
AI
Simonson Mathilde; Ancel Patricia; Mortier Romain; Mariko Mohamed Lamine; Fontaine Bénédicte; Koue Chon Lim Julie; Martel Jules; Nobécourt Estelle; Gaborit Bénédicte
Share
Save
Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study
Diabetes & Metabolism
IF
4.7
2025-11-09
0
PRE
AI
Lea Dehghani; Fideline Bonnet-Serrano; Hendy Abdul; Laure Alexandre-Heymann; Jean Guibourdenche; Etienne Larger
Share
Save
Handgrip strength cut-off points for identifying French adults at risk of type 2 diabetes
Diabetes & Metabolism
IF
4.7
2025-11-09
0
OA
AI
Thi Chi Phuong Nguyen; Jean-Michel Oppert; Laurent Bourhis; Alice Bellicha; Bernard Srour; Emmanuelle Kesse-Guyot; Serge Hercberg; Pilar Galan; Mathilde Touvier; Léopold K Fezeu; Jérémy Vanhelst
Share
Save
Increased epicardial adipose tissue is part of the phenotype of LMNA-associated partial lipodystrophy and could contribute to increased cardiovascular risk
Diabetes & Metabolism
IF
4.7
2025-10-25
0
PRE
AI
Sophie Lamothe; Patricia Ancel; Inès Belalem; Leïla Lecaque; Joris Fournel; Alexis Jacquier; Zouhair Houhou; Jean-Baptiste Julla; Jean-François Gautier; Corinne Vigouroux; Bénédicte Gaborit; Camille Vatier
Share
Save
Patient-reported outcome measures (PROMs) are differently associated with treatment modalities, household income, and diabetes-related events in children with type 1 diabetes, their mothers, and their fathers: a French nationwide survey
Diabetes & Metabolism
IF
4.7
2025-10-24
0
OA
AI
Emmanuelle Labarre; Laurent Poiroux; Marc De Kerdanet; Line Lobel; Bétina Porcel; Aurélie Donzeau; Carine Choleau; Jacques Beltrand; Regis Coutant
Share
Save
Management of patients with type 2 diabetes and MASLD: an overview and joint statement
Diabetes & Metabolism
IF
4.7
2025-10-15
0
PRE
AI
Yasmina Chouik; Clémence M Canivet; Jean-Baptiste Julla; Thomas Mouillot; Lucia Parlati; Alexia Rouland; Sarra Smati; Blandine Tramunt; Rodolphe Anty; Jérôme Boursier; Claire Carette; Bertrand Cariou; Laurent Castera; Armand Garioud; Bruno Guerci; Pierre Gourdy; Maeva Guillaume; Guillaume Lassailly; Raluca Pais; Jean-Michel Petit; Lawrence Serfaty; Bruno Vergès; Cyrielle Caussy
Share
Save
GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations
Diabetes & Metabolism
IF
4.7
2025-10-14
0
PRE
AI
André J. Scheen
Share
Save
Ulcer topography matters: hindfoot versus forefoot outcomes in first-time diabetic foot ulcer
Diabetes & Metabolism
IF
4.7
2025-10-10
0
PRE
AI
Muhammad Mohid Haroon
Share
Save
Epicardial adipose tissue volume and diabetic retinopathy
Diabetes & Metabolism
IF
4.7
2025-10-08
0
PRE
AI
Emmanuel Cosson; Sopio Tatulashvili; Marouane Boubaya; Amir Abdul Khalife; Imen Rezgani; Lucie Allard; Meriem Sal; Ines Barka; Mohamed Lamine Mariko; Mohamed Zerguine; Omar Nouhou Koutcha; Bénédicte Gaborit; Coralie Bloch-Queyrat; Pierre-Yves Brillet; Héloïse Torres-Villaros; Audrey Giocanti-Aurégan; Hélène Bihan
Share
Save
Comment on “Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study”
Diabetes & Metabolism
IF
4.7
2025-09-19
0
PRE
AI
Hamza Khan
Share
Save
Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks
Diabetes & Metabolism
IF
4.7
2025-09-18
0
OA
AI
Juliette Jacquot-Thierry; Sarah Chalopin; Héléna Mosbah; Émilie Montastier; Fabien Mourre; Blandine Gatta-Cherifi; Julien Bourry; Eléonore Guichard; Pauline Faucher; Christine Poitou; Chloé Amouyal
Share
Save
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study
Diabetes & Metabolism
IF
4.7
2025-09-12
0
PRE
AI
Beatriz Barquiel; Daniel Álvarez; Óscar Moreno Domínguez; Elena García-Pérez de Sevilla; Natalia Hillman; Ricardo Romero; Ruth Gaspar; Montserrat Arévalo; Noemí González-Perez de Villar
Share
Save
Peripheral neuropathy as a bedside marker for cerebral microangiopathy
Diabetes & Metabolism
IF
4.7
2025-09-12
0
PRE
AI
Muhammad Mohid Haroon
Share
Save
Modelled Substitution of Meat with Dairy Products and the 20-year Cumulative Incidence of Type 2 Diabetes: Insights from the ATTICA Cohort Study (2002–2022)
Diabetes & Metabolism
IF
4.7
2025-09-10
0
OA
AI
Ioanna Kechagia; Mary Yannakoulia; Fotios Barkas; Evangelos Liberopoulos; Petros P. Sfikakis; Christos Pitsavos; Demosthenes Panagiotakos
Share
Save
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort
Diabetes & Metabolism
IF
4.7
2025-09-05
0
OA
AI
Jean-Baptiste Julla; Théo Jolivet; Candice Estellat; Gaël Varoquaux; Aurélie Carlier; Jean-François Gautier; Julie Alberge; Yawa Abouleka; Audrey Bergès; Elise Liu; Judith Abecassis; Florence Tubach; Louis Potier
Share
Save
Prevalence and predictive factors of computed tomography-detected pancreatopathy in a cohort of adult patients hospitalized for newly diagnosed or uncontrolled non-auto-immune diabetes
Diabetes & Metabolism
IF
4.7
2025-08-27
0
PRE
AI
Noëmie Lemétayer; Lucille Quénéhervé; Jean-Romain Risson; Charlotte Nachtergaele; Geneviève Crouzeix; Emmanuel Sonnet; Nathalie Roudaut; Véronique Kerlan; Vianney Deméocq; Philippe Thuillier
Share
Save
SGLT2 Inhibitors and the Risk of Hepatocellular Carcinoma in Patients With MASLD and Type 2 Diabetes
Diabetes & Metabolism
IF
4.7
2025-08-22
0
PRE
AI
Ruey-Shyang Soong; Wan-Ming Chen; An-Tzu Jao; Ming-Che Lee; Szu-Yuan Wu; Chih-Lang Lin
Share
Save
Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database
Diabetes & Metabolism
IF
4.7
2025-08-18
0
PRE
AI
Nathanaël Bassas Letissier; Nassir Mirfendereski; Marie-Laure Laroche; Jean- Luc Faillie; Marc Paccalin; Pierre-Jean Saulnier; Marion Allouchery; Helena Mosbah
Share
Save